- Home
- MASS vs ENGN Comparison
MASS vs ENGN Comparison
Compare MASS & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- ENGN
- Stock Information
- Founded
- MASS 2012
- ENGN 1999
- Country
- MASS United States
- ENGN Canada
- Employees
- MASS N/A
- ENGN N/A
- Industry
- MASS Medical/Dental Instruments
- ENGN
- Sector
- MASS Health Care
- ENGN
- Exchange
- MASS Nasdaq
- ENGN Nasdaq
- Market Cap
- MASS 235.8M
- ENGN 191.1M
- IPO Year
- MASS 2020
- ENGN N/A
- Fundamental
- Price
- MASS $6.47
- ENGN $3.64
- Analyst Decision
- MASS Strong Buy
- ENGN Buy
- Analyst Count
- MASS 3
- ENGN 7
- Target Price
- MASS $8.00
- ENGN $23.29
- AVG Volume (30 Days)
- MASS 288.2K
- ENGN 100.8K
- Earning Date
- MASS 08-05-2025
- ENGN 09-09-2025
- Dividend Yield
- MASS N/A
- ENGN N/A
- EPS Growth
- MASS N/A
- ENGN N/A
- EPS
- MASS N/A
- ENGN N/A
- Revenue
- MASS $65,560,000.00
- ENGN N/A
- Revenue This Year
- MASS N/A
- ENGN N/A
- Revenue Next Year
- MASS $22.06
- ENGN N/A
- P/E Ratio
- MASS N/A
- ENGN N/A
- Revenue Growth
- MASS 37.93
- ENGN N/A
- 52 Week Low
- MASS $1.81
- ENGN $2.65
- 52 Week High
- MASS $8.06
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- MASS 45.31
- ENGN 48.30
- Support Level
- MASS $6.17
- ENGN $3.54
- Resistance Level
- MASS $6.79
- ENGN $4.10
- Average True Range (ATR)
- MASS 0.40
- ENGN 0.31
- MACD
- MASS -0.06
- ENGN -0.01
- Stochastic Oscillator
- MASS 47.27
- ENGN 27.14
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.